This trend is consistent with previous studies [17], suggesting that HER-2 overexpression may promote tumor cell dedifferentiation and malignant progression by activating downstream proliferative signaling pathways, such as PI3K/AKT/mTOR. This evidence concerns the gene MTOR and neoplasm.